New search Show text from Guidelines
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSL01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FX Other monoclonal antibodies and antibody drug conjugates
| ATC code | Name | DDD | U | Adm.R | Note |
| L01FX01 | edrecolomab | ||||
| L01FX02 | gemtuzumab ozogamicin | ||||
| L01FX03 | catumaxomab | ||||
| L01FX04 | ipilimumab | ||||
| L01FX05 | brentuximab vedotin | ||||
| L01FX06 | dinutuximab beta | ||||
| L01FX07 | blinatumomab | ||||
| L01FX08 | elotuzumab | ||||
| L01FX09 | mogamulizumab | ||||
| L01FX10 | olaratumab | ||||
| L01FX11 | bermekimab | ||||
| L01FX12 | tafasitamab | ||||
| L01FX13 | enfortumab vedotin | ||||
| L01FX14 | polatuzumab vedotin | ||||
| L01FX15 | belantamab mafodotin | ||||
| L01FX16 | oportuzumab monatox | ||||
| L01FX17 | sacituzumab govitecan | ||||
| L01FX18 | amivantamab | ||||
| L01FX19 | sabatolimab | ||||
| L01FX20 | tremelimumab | ||||
| L01FX21 | naxitamab | ||||
| L01FX22 | loncastuximab tesirine | ||||
| L01FX23 | tisotumab vedotin | ||||
| L01FX24 | teclistamab | ||||
| L01FX25 | mosunetuzumab | ||||
| L01FX26 | mirvetuximab soravtansine | ||||
| L01FX27 | epcoritamab | ||||
| L01FX28 | glofitamab | ||||
| L01FX29 | talquetamab | ||||
| L01FX31 | zolbetuximab | ||||
| L01FX32 | elranatamab | ||||
| L01FX33 | tarlatamab | ||||
| L01FX34 | odronextamab | ||||
| L01FX35 | datopotamab deruxtecan | ||||
| L01FX36 | patritumab deruxtecan |
Last updated: 2024-12-27